Showing results (1-10 of 83) with videos related to
Sort By:
Pageof 9
Immunology|February 26, 2026
Bruton's Tyrosine Kinase-Going Beyond the B CellRochelle Y Benoit, Sheila Loshi, Craig S MooreMultiple Sclerosis and Related Disorders|September 20, 2022
Does the use of the Bruton Tyrosine Kinase inhibitors and the c-kit inhibitor masitinib result in clinically significant outcomes among patients with various forms of multiple sclerosis?Shane Arsenault, Rochelle Y Benoit, Fraser Clift, et al.Immunohorizons|September 11, 2024
Bruton Tyrosine Kinase Inhibition Decreases Inflammation and Differentially Impacts Phagocytosis and Cellular Metabolism in Mouse- and Human-derived Myeloid CellsRochelle Y Benoit, Jennifer L Zagrodnik, Samantha J Carew, et al.The European Journal of Neuroscience|September 5, 2025
MiR-146b-5p Decreases Cytokine Release From Astrocytes and Preserves Oligodendrocyte Progenitor Cell Complexity During InflammationCassandra E Thompson, Sheila Loshi, Samantha J Carew, et al.Journal of Neurochemistry|May 28, 2022
Investigating the NLRP3 inflammasome and its regulator miR-223-3p in multiple sclerosis and experimental demyelinationDylan A Galloway, Samantha J Carew, Stephanie N Blandford, et al.The American Journal of Pathology|October 29, 2011
An alternate perspective on the roles of TIMPs and MMPs in pathologyCraig S Moore, Stephen J CrockerJournal of Pharmacological and Toxicological Methods|June 28, 2025
From cellular waste to biomarkers; insights into past, present, and future methods to detect immune cell-derived extracellular vesicles using flow cytometryJennifer L Zagrodnik, Craig S MooreFrontiers in Cell and Developmental Biology|July 6, 2016
miRNAs As Emerging Regulators of Oligodendrocyte Development and DifferentiationDylan A Galloway, Craig S MooreBMC Neurology|March 26, 2017
A critical review of manual therapy use for headache disorders: prevalence, profiles, motivations, communication and self-reported effectivenessCraig S Moore, David W Sibbritt, Jon AdamsJournal of Neuroimmunology|May 12, 2009
Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: Effects of darbepoetin alfa on TIMP-1 null and wild-type miceMichael Thorne, Craig S Moore, George S RobertsonPageof 9